{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T20:01:30Z","timestamp":1792353690116,"version":"4.4.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Academy of Child & Adolescent Psychiatry"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1097\/chi.0b013e3181b26e9f","type":"journal-article","created":{"date-parts":[[2009,8,14]],"date-time":"2009-08-14T07:12:15Z","timestamp":1250233935000},"page":"884-893","source":"Crossref","is-referenced-by-count":221,"title":["Meta-Analysis: Treatment of Attention-Deficit\/Hyperactivity Disorder in Children With Comorbid Tic Disorders"],"prefix":"10.1016","volume":"48","author":[{"given":"Michael H.","family":"Bloch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaitlyn E.","family":"Panza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angeli","family":"Landeros-Weisenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James F.","family":"Leckman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1097\/CHI.0b013e3181b26e9f_bib1","series-title":"Physicians' Desk Reference","year":"2007"},{"key":"10.1097\/CHI.0b013e3181b26e9f_bib2","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/00002826-199210000-00010","article-title":"Pharmacologic controversy of CNS stimulants in Gilles de la Tourette's syndrome","volume":"15","author":"Robertson","year":"1992","journal-title":"Clin Neuropharmacol"},{"key":"10.1097\/CHI.0b013e3181b26e9f_bib3","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1097\/01.chi.0000251210.98749.83","article-title":"Psychopathology in a Swedish population of school children with tic disorders","volume":"45","author":"Khalifa","year":"2006","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1097\/CHI.0b013e3181b26e9f_bib4","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1111\/1469-7610.00406","article-title":"Disentangling the overlap between Tourette's disorder and ADHD","volume":"39","author":"Spencer","year":"1998","journal-title":"J Child Psychol Psychiatry"},{"key":"10.1097\/CHI.0b013e3181b26e9f_bib5","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/00004583-200301000-00016","article-title":"Disruptive behavior in children with Tourette's syndrome: association with ADHD comorbidity, tic severity, and functional impairment","volume":"42","author":"Sukhodolsky","year":"2003","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"10 Suppl","key":"10.1097\/CHI.0b013e3181b26e9f_bib6","doi-asserted-by":"crossref","first-page":"85S","DOI":"10.1097\/00004583-199710001-00007","article-title":"Practice parameters for the assessment and treatment of children, adolescents, and adults with attention-deficit\/hyperactivity disorder. American Academy of Child and Adolescent Psychiatry","volume":"36","author":"Dulcan","year":"1997","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1097\/CHI.0b013e3181b26e9f_bib7","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.cpr.2007.10.007","article-title":"Efficacy of methylphenidate, psychosocial treatments and their combination in school-aged children with ADHD: a meta-analysis","volume":"28","author":"Van der Oord","year":"2008","journal-title":"Clin Psychol Rev"},{"key":"10.1097\/CHI.0b013e3181b26e9f_bib8","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1001\/archpsyc.56.12.1073","article-title":"A 14-month randomized clinical trial of treatment strategies for attention-deficit\/hyperactivity disorder. Multimodal Treatment Study of Children with ADHD","volume":"56","author":"The MTA Cooperative Group","year":"1999","journal-title":"Arch Gen Psychiatry"},{"key":"10.1097\/CHI.0b013e3181b26e9f_bib9","first-page":"4","article-title":"Comparing the efficacy of medications for ADHD using meta-analysis","volume":"8","author":"Faraone","year":"2006","journal-title":"MedGenMed"},{"key":"10.1097\/CHI.0b013e3181b26e9f_bib10","first-page":"i","article-title":"Treatment of attention-deficit\/hyperactivity disorder","author":"Jadad","year":"1999","journal-title":"Evid Rep Technol Assess (Summ)"},{"key":"10.1097\/CHI.0b013e3181b26e9f_bib11","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/00004583-199604000-00008","article-title":"Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle","volume":"35","author":"Spencer","year":"1996","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1097\/CHI.0b013e3181b26e9f_bib12","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/ana.410020113","article-title":"The effect of central nervous system stimulants on Tourette syndrome","volume":"2","author":"Golden","year":"1977","journal-title":"Ann Neurol"},{"key":"10.1097\/CHI.0b013e3181b26e9f_bib13","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/jama.1976.03260390035024","article-title":"Tics following methylphenidate administration. A report of 20 cases","volume":"235","author":"Denckla","year":"1976","journal-title":"JAMA"},{"key":"10.1097\/CHI.0b013e3181b26e9f_bib14","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1001\/jama.1982.03320330064029","article-title":"Stimulant medications precipitate Tourette's syndrome","volume":"247","author":"Lowe","year":"1982","journal-title":"JAMA"},{"key":"10.1097\/CHI.0b013e3181b26e9f_bib15","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.biopsych.2004.10.011","article-title":"The dopamine transporter and attention-deficit\/hyperactivity disorder","volume":"57","author":"Madras","year":"2005","journal-title":"Biol Psychiatry"},{"key":"10.1097\/CHI.0b013e3181b26e9f_bib16","first-page":"99","article-title":"Neurobiology of basal ganglia and Tourette syndrome: striatal and dopamine function","volume":"99","author":"Albin","year":"2006","journal-title":"Adv Neurol"},{"key":"10.1097\/CHI.0b013e3181b26e9f_bib17","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0887-8994(01)00262-4","article-title":"Basal ganglia dysfunction in Tourette's syndrome: a new hypothesis","volume":"25","author":"Mink","year":"2001","journal-title":"Pediatr Neurol"},{"key":"10.1097\/CHI.0b013e3181b26e9f_bib18","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(02)11526-1","article-title":"Tourette's syndrome","volume":"360","author":"Leckman","year":"2002","journal-title":"Lancet"},{"key":"10.1097\/CHI.0b013e3181b26e9f_bib19","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/00004583-198403000-00007","article-title":"Controlled study of pimozide vs. placebo in Tourette's syndrome","volume":"23","author":"Shapiro","year":"1984","journal-title":"J Am Acad Child Psychiatry"},{"key":"10.1097\/CHI.0b013e3181b26e9f_bib20","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/BF02168939","article-title":"Observations and ratings of tics in school settings","volume":"22","author":"Nolan","year":"1994","journal-title":"J Abnorm Child Psychol"},{"key":"10.1097\/CHI.0b013e3181b26e9f_bib21","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/00004583-198907000-00015","article-title":"The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity","volume":"28","author":"Leckman","year":"1989","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1097\/CHI.0b013e3181b26e9f_bib22","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/00004583-199205000-00013","article-title":"The validity of instruments measuring tic severity in Tourette's syndrome","volume":"31","author":"Walkup","year":"1992","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1097\/CHI.0b013e3181b26e9f_bib23","series-title":"Manual for the Child Behavior Checklist","author":"Achenbach","year":"1991"},{"key":"10.1097\/CHI.0b013e3181b26e9f_bib24","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/BF00916752","article-title":"Conners' Teacher Rating Scale for use in drug studies with children\u2013an empirical study","volume":"3","author":"Werry","year":"1975","journal-title":"J Abnorm Child Psychol"},{"key":"10.1097\/CHI.0b013e3181b26e9f_bib25","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1207\/s15374424jccp2003_3","article-title":"Parent and teacher rating of ADHD symptoms: psychometric properties in a community-based sample","volume":"20","author":"DuPaul","year":"1991","journal-title":"J Clin Child Psychol"},{"key":"10.1097\/CHI.0b013e3181b26e9f_bib26","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1207\/s15374424jccp1803_9","article-title":"Normative data on the Iowa Conners teacher rating scale","volume":"1989","author":"Pelham","year":"1989","journal-title":"J Clin Child Psychol"},{"key":"10.1097\/CHI.0b013e3181b26e9f_bib27","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/BF00919127","article-title":"Normative data on revised Conners Parent and Teacher Rating Scales","volume":"6","author":"Goyette","year":"1978","journal-title":"J Abnorm Child Psychol"},{"key":"10.1097\/CHI.0b013e3181b26e9f_bib28","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"Int J Epidemiol"},{"key":"10.1097\/CHI.0b013e3181b26e9f_bib29","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1002\/sim.1205","article-title":"Meta-analysis combining parallel and cross-over clinical trials. I: Continuous outcomes","volume":"21","author":"Curtin","year":"2002","journal-title":"Stat Med"},{"key":"10.1097\/CHI.0b013e3181b26e9f_bib30","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.biopsych.2007.05.019","article-title":"Systematic review: pharmacological and behavioral treatment for trichotillomania","volume":"62","author":"Bloch","year":"2007","journal-title":"Biol Psychiatry"},{"key":"10.1097\/CHI.0b013e3181b26e9f_bib31","unstructured":"Review Manager (RevMan) [computer program]. Version 4.2 for Windows. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration; 2003."},{"key":"10.1097\/CHI.0b013e3181b26e9f_bib32","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1097\/CHI.0b013e3181b26e9f_bib33","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/00004583-199705000-00008","article-title":"Controlled stimulant treatment of ADHD and comorbid Tourette's syndrome: effects of stimulant and dose","volume":"36","author":"Castellanos","year":"1997","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1097\/CHI.0b013e3181b26e9f_bib34","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/00004583-199205000-00012","article-title":"Methylphenidate in hyperactive boys with comorbid tic disorder: II. Short-term behavioral effects in school settings","volume":"31","author":"Gadow","year":"1992","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1097\/CHI.0b013e3181b26e9f_bib35","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1097\/chi.0b013e31805c0860","article-title":"Immediate-release methylphenidate for ADHD in children with comorbid chronic multiple tic disorder","volume":"46","author":"Gadow","year":"2007","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1097\/CHI.0b013e3181b26e9f_bib36","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1176\/appi.ajp.158.7.1067","article-title":"A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder","volume":"158","author":"Scahill","year":"2001","journal-title":"Am J Psychiatry"},{"key":"10.1097\/CHI.0b013e3181b26e9f_bib37","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1212\/01.wnl.0000188869.58300.a7","article-title":"Atomoxetine treatment in children and adolescents with ADHD and comorbid tic disorders","volume":"65","author":"Allen","year":"2005","journal-title":"Neurology"},{"key":"10.1097\/CHI.0b013e3181b26e9f_bib38","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1212\/WNL.58.4.527","article-title":"Treatment of ADHD in children with tics: a randomized controlled trial","volume":"58","author":"Tourette's Syndrome Study Group","year":"2002","journal-title":"Neurology"},{"key":"10.1097\/CHI.0b013e3181b26e9f_bib39","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1542\/peds.95.1.74","article-title":"The treatment of attention-deficit hyperactivity disorder in Tourette's syndrome: a double-blind placebo-controlled study with clonidine and desipramine","volume":"95","author":"Singer","year":"1995","journal-title":"Pediatrics"},{"key":"10.1097\/CHI.0b013e3181b26e9f_bib40","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1001\/archpsyc.59.7.649","article-title":"A double-blind comparison of desipramine and placebo in children and adolescents with chronic tic disorder and comorbid attention-deficit\/hyperactivity disorder","volume":"59","author":"Spencer","year":"2002","journal-title":"Arch Gen Psychiatry"},{"key":"10.1097\/CHI.0b013e3181b26e9f_bib41","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1212\/WNL.46.4.965","article-title":"A controlled trial of deprenyl in children with Tourette's syndrome and attention deficit hyperactivity disorder","volume":"46","author":"Feigin","year":"1996","journal-title":"Neurology"},{"key":"10.1097\/CHI.0b013e3181b26e9f_bib42","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1177\/1087054707306109","article-title":"Atomoxetine treatment of ADHD in children with comorbid Tourette syndrome","volume":"11","author":"Spencer","year":"2008","journal-title":"J Atten Disord"},{"key":"10.1097\/CHI.0b013e3181b26e9f_bib43","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1001\/archpsyc.1995.03950180030005","article-title":"Efficacy of methylphenidate for attention-deficit hyperactivity disorder in children with tic disorder","volume":"52","author":"Gadow","year":"1995","journal-title":"Arch Gen Psychiatry"},{"key":"10.1097\/CHI.0b013e3181b26e9f_bib44","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/0269881103017001714","article-title":"A placebo-controlled study of lofexidine in the treatment of children with tic disorders and attention deficit hyperactivity disorder","volume":"17","author":"Niederhofer","year":"2003","journal-title":"J Psychopharmacol"},{"key":"10.1097\/CHI.0b013e3181b26e9f_bib45","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1177\/026988110401800301","article-title":"An exceptional case of plagiarism!","volume":"18","author":"Bailey","year":"2004","journal-title":"J Psychopharmacol"},{"key":"10.1097\/CHI.0b013e3181b26e9f_bib46","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1177\/1087054708319345","article-title":"Evidence, interpretation, and qualification from multiple reports of long-term outcomes in the Multimodal Treatment study of Children With ADHD (MTA): part I: executive summary","volume":"12","author":"Swanson","year":"2008","journal-title":"J Atten Disord"},{"key":"10.1097\/CHI.0b013e3181b26e9f_bib47","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1001\/archpsyc.1986.01800120054011","article-title":"Rebound phenomena in Tourette's syndrome after abrupt withdrawal of clonidine. Behavioral, cardiovascular, and neurochemical effects","volume":"43","author":"Leckman","year":"1986","journal-title":"Arch Gen Psychiatry"},{"key":"10.1097\/CHI.0b013e3181b26e9f_bib48","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1097\/00004583-198911000-00015","article-title":"A double-blind placebo controlled study of desipramine in the treatment ADD: II. Serum drug levels and cardiovascular findings","volume":"28","author":"Biederman","year":"1989","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1097\/CHI.0b013e3181b26e9f_bib49","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.nurx.2006.01.009","article-title":"Contemporary assessment and pharmacotherapy of Tourette syndrome","volume":"3","author":"Scahill","year":"2006","journal-title":"NeuroRx"},{"key":"10.1097\/CHI.0b013e3181b26e9f_bib50","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1097\/00004583-199905000-00025","article-title":"Combining methylphenidate and clonidine: a clinically sound medication option","volume":"38","author":"Wilens","year":"1999","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1097\/CHI.0b013e3181b26e9f_bib51","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/chi.0b013e31815d9ae4","article-title":"Clonidine for attention-deficit\/hyperactivity disorder: II. ECG changes and adverse events analysis","volume":"47","author":"Daviss","year":"2008","journal-title":"JAm Acad Child Adolesc Psychiatry"},{"key":"10.1097\/CHI.0b013e3181b26e9f_bib52","first-page":"1475","article-title":"How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents? A meta-analysis","volume":"165","author":"Schachter","year":"2001","journal-title":"CMAJ"},{"key":"10.1097\/CHI.0b013e3181b26e9f_bib53","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1097\/00004583-199912000-00017","article-title":"A meta-analysis of clonidine for symptoms of attention-deficit hyperactivity disorder","volume":"38","author":"Connor","year":"1999","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1097\/CHI.0b013e3181b26e9f_bib54","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00213-007-0840-x","article-title":"Efficacy and safety of atomoxetine for attention-deficit\/hyperactivity disorder in children and adolescents-meta-analysis and meta-regression analysis","volume":"194","author":"Cheng","year":"2007","journal-title":"Psychopharmacology (Berl)"}],"container-title":["Journal of the American Academy of Child & Adolescent Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890856709601441?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890856709601441?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T10:07:33Z","timestamp":1685095653000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890856709601441"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":54,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["S0890856709601441"],"URL":"https:\/\/doi.org\/10.1097\/chi.0b013e3181b26e9f","relation":{},"ISSN":["0890-8567"],"issn-type":[{"value":"0890-8567","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}